Management Team

The executive leadership of Ikonisys is comprised of the following industry and business veterans:

Mario Crovetto

Mario Crovetto has a long experience in the healthcare sector, having covered several general management roles in pharma and diagnostics companies. He previously served as CFO of Eurand NV, a specialty pharmaceutical company which he successfully floated to NASDAQ in 2007. He also held multiple executive functions in the pharmaceutical and chemical sectors, including positions as CFO of the Recordati Group and Finance positions at the Montedison Group. He currently serves as a Board Member of OpGen Inc, an international molecular diagnosis company based in USA. Mr Crovetto holds an MSc in Business Economics from Harvard University.


Michael W Kilpatrick, PhD

CSO & Founder
Dr. Kilpatrick obtained his PhD in Chemistry in 1981 from the University of Birmingham, UK for his studies on the ribonucleic acid of mycoplasma. Following periods as a postdoctoral research fellow at the University of Winsconsin-Madison, the University of Alabama at Birmingham and the Imperial Cancer Research Fund laboratories in London, he joined the faculty of the University of Birmingham as the Wellcome Trust Lecturer in Molecular Genetics, where he was responsible for the introduction of a molecular program for the study of human genetic disease. Subsequently, Dr. Kilpatrick joined the faculty of the University of Connecticut Health Center where his collaborations with Dr. Tsipouras and Dr. Tafas began. Dr. Kilpatrick has more than 100 scientific publications in the fields of nucleic acid structure and function and human molecular genetics, and has served on NIH study sections. His research has been funded by the Medical Research Council, the Wellcome Trust, NATO, the Arthritis and Rheumatism Council and the NIH.


Bill Kochiss


Bill Kochiss has been managing various manufacturing operations for the past 15 years. Prior to that, Bill worked in purchasing, planning, and scheduling. Throughout his 20+ year career Bill has experienced success working for a wide variety of organizations. The businesses ranged in size from multi-million dollar publicly traded medical manufacturing corporations to biotech startups. This widely varying corporate background enabled Bill to gain an expansive skill set. His expertise managing in the tightly regulated environments of medical and aerospace manufacturing enables to find creative yet realistic solutions. He is driven by a passion for growth and new challenges.

Regardless of organization size, Bill believes in leading by example and working with cross-functional teams to achieve corporate objectives. These work ethics have enabled Bill to have success with new product releases, redesigns, and business growth. Throughout Bill’s career, he has been able to facilitate changes and improvements to continually help the organizations move forward and succeed.


Jurgen Schipper

Juergen Schipper has more than 20 years of experience in General Management, Business and Commercial Development. He is the Founder and Managing Director of Microbionix GmBH, a German company specialised in the development of Multiplex Assay Systems. He is also the Founder and CEO of Diagnostics & Life Science Consulting. Mr Schipper has occupied multiple interim management positions at companies such as Luminex Corporation and Omega Diagnostics GmbH and holds an MBA from Munich University of Applied Sciences.


Alessandro Mauri

Alessandro Mauri has worked as a Portfolio Manager in Cambria, Ltd. a UK private equity firm regulated by CFA. Before that, he has acted both as CEO and CFO of B10NIX, an innovative biotech startup in the field of biological signal analysis with the use of artificial intelligence. For his work in B10NIX he was awarded several awards and prizes, including the Alumni Polimi Award 2014, a prize awarded every year from Politecnico di Milano's alumni association to outstanding ex-students. Mr Mauri holds an M.Sc. in Global Finance from Fordham University (New York, USA) a Master in Corporate Finance from SDA Bocconi (Milano, Italy) and an M.Sc. in Engineering of Computing Systems from Politecnico di Milano (Milano, Italy).